PHVS Stock Analysis: Buy, Sell, or Hold?

PHVS - Pharvaris N.V. Ordinary Shares

Pharmaceutical Preparations
$30.66
-0.24 (-0.78%) ▼
5d: +2.13%
30d: -12.9%
90d: -7.82%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026 19d

Get Alerted When PHVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: PHVS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: PHVS is currently trading at $30.66, which is considered fair relative to its 30-day fair value range of $29.76 to $35.86.

Technical Outlook: Technically, PHVS is showing sideways momentum. Immediate support is located at $27.68, while resistance sits at $31.96.

Market Sentiment: PHVS scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $57.67 (+88.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $29.76 - $35.86
Company Quality Score 62/100 (BUY)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (74/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 88.1% below Wall St target ($57.67)
  • BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up

Trading Range Analysis

30-Day Trading Range $29.76 - $35.86
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $27.68
Resistance Level $31.96
Current Trend Sideways
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -11.27
Wall Street Target $57.67 (+88.1%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 22, 2026 7:39 AM ET
Data refreshes hourly during market hours. Next update: 8:39 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PHVS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
INSM
Insmed Inc
STRONG BUY
24 analysts
$197 60 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$109 66 BUY
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$686 59 HOLD
CGON
CG Oncology, Inc. Common…
STRONG BUY
15 analysts
$91 73 BUY
IMNM
Immunome Inc
STRONG BUY
16 analysts
$35 63 BUY

Advanced PHVS Option Strategies

Professional options setups generated by AI based on today's PHVS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PHVS

PHVS Technical Chart PHVS Price Prediction PHVS Earnings Date PHVS Investment Advisor PHVS Fair Price Analyzer PHVS Options Advisor PHVS Options Chain PHVS Options Analysis PHVS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals